Lawrence A. Leiter

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

9.0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

Journal of Diabetes Science and Technology(2022)10.1177/19322968221085273

Top 2%

9.0DataRank

Top 2%282 citations

Jing Wang, David Rodbard, Michael A. Kohn, Chengdong Li, Dorian Liepmann +89 more

Papers

Driven by 17 papers — median percentile 98. Top paper: “A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings”.

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

Journal of Diabetes Science and Technology(2022)10.1177/19322968221085273

Top 2%

9.0DataRank

Top 2%282 citations

Jing Wang, David Rodbard, Michael A. Kohn, Chengdong Li, Dorian Liepmann +89 more

Relation of Change or Substitution of Low- and No-Calorie Sweetened Beverages With Cardiometabolic Outcomes: A Systematic Review and Meta-analysis of Prospective Cohort Studies

Diabetes Care(2022)10.2337/dc21-2130

N/A

2.4DataRank · unranked

69 citations

Tauseef Khan, Néma McGlynn, Vasanti Malik, James O. Hill, Lawrence A. Leiter +7 more

Important Food Sources of Fructose-Containing Sugars and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Controlled Trials

Nutrients(2022)10.3390/nu14142846

N/A

1.5DataRank · unranked

58 citations

Laura Chiavaroli, Sabrina Ayoub-Charette, Tauseef Khan, Andreea Zurbau, Fei Au-Yeung +15 more

Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial

Circulation(2022)10.1161/circulationaha.122.062769

N/A

1.1DataRank · unranked

35 citations

C. David Mazer, Pankaj Puar, Hwee Teoh, Chao‐Hung Wang, Tamique Mason +29 more

Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial

The Lancet Diabetes & Endocrinology(2025)10.1016/s2213-8587(24)00362-0

N/A

0.700DataRank · unranked

31 citations

Deepak L. Bhatt, Michael Szarek, Christopher P. Cannon, Lawrence A. Leiter, Silvio E. Inzucchi +17 more

Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials

Journal of clinical lipidology(2020)10.1016/j.jacl.2020.08.009

N/A

0.695DataRank · unranked

102 citations

Maciej Banach, Alberico L. Catapano, P. Barton Duell, Antonio M. Gotto, Ulrich Laufs +8 more

Galectin-3 and Kidney Function in Type 2 Diabetes Treated with Dapagliflozin: Analysis from DECLARE-TIMI 58

ESC Heart Failure(2025)10.1002/ehf2.15415

N/A

0.220DataRank · unranked

3 citations

Stephen D. Wiviott, David D. Berg, Petr Jarolı́m, Erica L. Goodrich, Deepak L. Bhatt +8 more

External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry

International Journal of Cardiology(2022)10.1016/j.ijcard.2022.10.132

N/A

0.187DataRank · unranked

2 citations

Deepak L. Bhatt, Yedid Elbez, Grégory Ducrocq, Shinya Goto, Sidney C. Smith +15 more

Effect of lowering the glycemic load with canola oil on glycemic control and cardiovascular risk factors: a randomized controlled trial

Figshare(2024)10.32920/26521303.v1

N/A

0DataRank · unranked

0 citations

Cyril W.C. Kendall, Vladimir Vuksan, Dorothea Faulkner, Livia S. A. Augustin, Sandra A. Mitchell +16 more

Natriuretic Peptides, Body Mass Index and Heart Failure Risk: Pooled Analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61

European Journal of Heart Failure(2023)10.1002/ejhf.3118

N/A

0DataRank · unranked

9 citations

David A. Morrow, Andrea Bellavia, David D. Berg, Deepak L. Bhatt, Petr Jarolı́m +11 more

Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events

JACC Heart Failure(2023)10.1016/j.jchf.2023.05.026

N/A

0DataRank · unranked

46 citations

Deepak L. Bhatt, Michael Szarek, Christopher P. Cannon, Lawrence A. Leiter, Darren K. McGuire +17 more

Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society

Progress in Cardiovascular Diseases(2023)10.1016/j.pcad.2023.05.002

N/A

0DataRank · unranked

22 citations

Jingtong Huang, Ambarish Pandey, Ibrahim A. Hashim, David Kerr, Rodica Pop‐Busui +30 more

Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus

Circulation(2020)10.1161/circulationaha.119.041022

N/A

0DataRank · unranked

109 citations

Neha J. Pagidipati, Robert M. Califf, Darren K. McGuire, Jennifer B. Green, Dave DeMets +16 more

Effects of albiglutide on myocardial infarction and ischaemic heart disease outcomes in patients with type 2 diabetes and cardiovascular disease in the Harmony Outcomes trial

European Heart Journal - Cardiovascular Pharmacotherapy(2024)10.1093/ehjcvp/pvae006

N/A

0DataRank · unranked

15 citations

Guillaume Marquis‐Gravel, Shannon Murphy, Karen P. Alexander, Karen Chiswell, Jennifer B. Green +8 more

Time to Clinical Benefit with Sotagliflozin in Patients with Type 2 Diabetes and Chronic Kidney Disease: Insights from the SCORED Randomized Trial

European Journal of Heart Failure(2024)10.1002/ejhf.3240

N/A

0DataRank · unranked

4 citations

Deepak L. Bhatt, Michael Szarek, Lawrence A. Leiter, Christopher P. Cannon, Renato D. Lópes +5 more

Risk of new‐onset diabetes and efficacy of pharmacological weight loss therapy

Diabetes Obesity and Metabolism(2024)10.1111/dom.15798

N/A

0DataRank · unranked

2 citations

Andrea Bellavia, David D. Berg, Giorgio Melloni, Mark W. Feinberg, Lawrence A. Leiter +6 more

External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry

UNC Libraries(2024)10.17615/2cg0-4859

N/A

0DataRank · unranked

0 citations

Philippe Gabríel Steg, Ivo Petrov, Yedid Elbez, Tabassome Simon, Eli I. Lev +16 more

Lawrence A. Leiter

Indexed papers

Top data-sharing exemplar

Papers